The fluorescent cytoprint assay in gynecological malignancies and breast cancer. Methodology and results
Blackman, K.E.; Fingert, H.J.; Fuller, A.F.; Meitner, P.A.
Contributions to Gynecology and Obstetrics 19: 53-63
1994
ISSN/ISBN: 0304-4246 PMID: 7995053 Document Number: 430846
Document emailed within 1 workday
Related Documents
Meitner, P.A. 1991: The fluorescent cytoprint assay: a new approach to in vitro chemosensitivity testing Oncology 5(9): 75-81; Discussion: 81-2 85 88Sarkar, M.; Konar, H.; Raut, D.K. 2011: Knowledge and health care-seeking behavior in relation to gynecological malignancies in India: a study of the patients with gynecological malignancies in a tertiary care hospital of Kolkata Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 26(2): 348-354
Sekiguchi, I.; Suzuki, M.; Aida, I.; Tamada, T.; Nishida, M. 1990: Responsiveness of gynecological malignancies to oral antitumor agents in subrenal capsule assay and individualization of oral adjuvant chemotherapy Nihon Sanka Fujinka Gakkai Zasshi 42(5): 437-442
Sun, X.; Liu, J-Juan.; Wang, Y-Sheng.; Song, X-Rang.; Zhong, W-Xia.; Zhou, C-Chun.; Mu, D-Bin.; Zuo, W-Shu.; Yu, Z-Yong.; Zhou, Z-Bo. 2011: Using intra-operative GeneSearchTM Breast Lymph Node Assay to detect breast cancer metastases in sentinel lymph nodes: results from a single institute in China Chinese Medical Journal 124(7): 973-977
Iglesias, J.; Borras, G.; Lailla, J.M.; Fortuny, A.; Molina, R.; Ballesta, A.; Sentís, J. 1988: Total LDH and its isoenzymes in gynecological malignancies and other gynecological conditions European Journal of Gynaecological Oncology 9(1): 32-35
Mittra, I.; Mishra, G.A.; Singh, S.; Aranke, S.; Notani, P.; Badwe, R.; Miller, A.B.; Daniel, E.E.; Gupta, S.; Uplap, P.; Thakur, M.H.; Ramani, S.; Kerkar, R.; Ganesh, B.; Shastri, S.S. 2010: A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening International Journal of Cancer 126(4): 976-984
Regidor, P.A.; Nelken, B.; Regidor, M.; Bier, U.; Oberhoff, C.; Schindler, A.E. 1996: Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies Zentralblatt für Gynakologie 118(3): 148-153
Johnson, R.B.; Nakamura, R.M. 1978: Simplified Scatchard plot assay for progesterone receptor in breast cancer: comparison with single-point and multipoint assay Clinical Chemistry 24(7): 1170-1176
Fujimitsu, R.; Nomoto, S.; Kuwabara, Y.; Shimakura, M.; Yoshimitsu, K. 2012: Second malignancies in breast cancer patients after radiotherapy Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 7): 97-100
Edynak, E.M.; Hirshaut, Y.; Bernhard, M.; Trempe, G. 1972: Fluorescent antibody studies of human breast cancer Journal of the National Cancer Institute 48(4): 1137-1143
Ohsumi, S. 2016: Hereditary Breast and Ovarian Cancer--From the Gynecological Viewpoint Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(2): 189-192
Curtis, M.A. 2003: New monoclonal antibodies for hematologic malignancies (and breast cancer) Medicine and Health Rhode Island 86(8): 256-257
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Plu-Bureau, G. 1995: Oral contraception and risk of cancer. Epidemiological aspects of breast and gynecological cancers La Revue du Praticien 45(19): 2441-2444
Menis, M.; Toso, C.; Rocco, M.; Pizzolitto, S.; Antoci, B. 1985: Comparison and correlations of results obtained in the study of steroid receptors using fluorescent histochemical and radiometric methods in 300 cases of breast neoplasms Pathologica 77(1049): 299-303
Sidoni, A.; Ferri, I.; Cavaliere, A.; Bellezza, G.; Scheibel, M.; Bucciarelli, E. 2006: Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization Anticancer Research 26(3b): 2333-2337
Jamal, S.; Mamoon, N.; Mushtaq, S.; Luqman, M.; Moghal, S. 2006: The pattern of gynecological malignancies in 968 cases from Pakistan Annals of Saudi Medicine 26(5): 382-384
Nandakumar, A.; Anantha, N.; Venugopal, T.C. 1998: Population-based survival from breast and cervical cancer and lymphoreticular malignancies in Bangalore, India Iarc Scientific Publications 145: 61-68
Nandakumar, A.; Anantha, N.; Venugopal, T.C. 1998: Population-based survival from breast and cervical cancer and lymphoreticular malignancies in Bangalore, India Iarc Scientific Publications 145: 61-68